Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B L Fish

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Radiation Research|December 1, 1992
Treatment of radiation nephropathy with captoprilE P Cohen, B L Fish, J E Moulder
Radiation Research|November 7, 1998
Brief pharmacological intervention in experimental radiation nephropathyJ E Moulder, B L Fish, E P Cohen
Current Pharmaceutical Design|May 18, 2007
Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonistsJ E Moulder, B L Fish, E P Cohen
International Journal of Radiation Biology|May 20, 1998
Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathyJ E Moulder, B L Fish, E P Cohen
The Journal of Laboratory and Clinical Medicine|May 1, 1997
Successful brief captopril treatment in experimental radiation nephropathyE P Cohen, B L Fish, J E Moulder
International Journal of Radiation Biology|December 6, 2002
Dietary sodium modification and experimental radiation nephropathyJ E Moulder, B L Fish, E P Cohen
Bone Marrow Transplantation|April 1, 1997
Noncontinuous use of angiotensin converting enzyme inhibitors in the treatment of experimental bone marrow transplant nephropathyJ E Moulder, B L Fish, E P Cohen
International Journal of Radiation Oncology, Biology, Physics|March 1, 1994
Effect of nephrotoxic drugs on the development of radiation nephropathy after bone marrow transplantationC A Lawton, B L Fish, J E Moulder
The Journal of Laboratory and Clinical Medicine|September 11, 1999
Angiotensin II infusion exacerbates radiation nephropathyE P Cohen, B L Fish, J E Moulder
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 1998
Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonistJ E Moulder, B L Fish, E P Cohen
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Radiation Research|December 1, 1992
Treatment of radiation nephropathy with captoprilE P Cohen, B L Fish, J E Moulder
Radiation Research|November 7, 1998
Brief pharmacological intervention in experimental radiation nephropathyJ E Moulder, B L Fish, E P Cohen
Current Pharmaceutical Design|May 18, 2007
Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonistsJ E Moulder, B L Fish, E P Cohen
International Journal of Radiation Biology|May 20, 1998
Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathyJ E Moulder, B L Fish, E P Cohen
The Journal of Laboratory and Clinical Medicine|May 1, 1997
Successful brief captopril treatment in experimental radiation nephropathyE P Cohen, B L Fish, J E Moulder
International Journal of Radiation Biology|December 6, 2002
Dietary sodium modification and experimental radiation nephropathyJ E Moulder, B L Fish, E P Cohen
Bone Marrow Transplantation|April 1, 1997
Noncontinuous use of angiotensin converting enzyme inhibitors in the treatment of experimental bone marrow transplant nephropathyJ E Moulder, B L Fish, E P Cohen
International Journal of Radiation Oncology, Biology, Physics|March 1, 1994
Effect of nephrotoxic drugs on the development of radiation nephropathy after bone marrow transplantationC A Lawton, B L Fish, J E Moulder
The Journal of Laboratory and Clinical Medicine|September 11, 1999
Angiotensin II infusion exacerbates radiation nephropathyE P Cohen, B L Fish, J E Moulder
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 1998
Radiation nephropathy is treatable with an angiotensin converting enzyme inhibitor or an angiotensin II type-1 (AT1) receptor antagonistJ E Moulder, B L Fish, E P Cohen
Pageof 5